Skip to main content
Thorax logoLink to Thorax
. 1992 Nov;47(11):910–913. doi: 10.1136/thx.47.11.910

Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up.

B Yuksel 1, A Greenough 1
PMCID: PMC464091  PMID: 1465747

Abstract

BACKGROUND: Preterm infants often suffer from recurrent respiratory symptoms at follow up. Although these infants are responsive to treatment with bronchodilators some continue to wheeze or cough despite treatment. In a randomised double blind placebo controlled trial, the ability of inhaled steroids to reduce recurrent respiratory symptoms and the requirement for bronchodilator treatment in preterm infants less than two years of age has been assessed. METHODS: Eighteen premature infants with mean gestational age 28 weeks and postnatal age 10.5 months were recruited. The study consisted of two six week treatment periods separated by a two week washout period. The infants received either 200 micrograms of beclomethasone dipropionate or placebo as one puff twice daily from an inhaler, through a spacer and a face mask. Parents kept a daily record of their infants' respiratory tract symptoms (wheeze and cough) and use of bronchodilators. Functional residual capacity (FRC) was measured at the beginning and end of each six week period. RESULTS: The symptom score was reduced by 37% in the active compared with the placebo period. During the active period the infants had a mean of 28 bronchodilator free days, compared with 22 days in the placebo period. The FRC improved significantly in the active but not the placebo period. CONCLUSION: Regular dosage with beclomethasone by inhalation is a useful treatment for preterm infants with respiratory symptoms.

Full text

PDF
910

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bisgaard H., Munck S. L., Nielsen J. P., Petersen W., Ohlsson S. V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet. 1990 Sep 15;336(8716):649–651. doi: 10.1016/0140-6736(90)92147-a. [DOI] [PubMed] [Google Scholar]
  2. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–310. [PubMed] [Google Scholar]
  3. Bowman E., Yu V. Y. Continuing morbidity in extremely low birthweight infants. Early Hum Dev. 1988 Dec;18(2-3):165–174. doi: 10.1016/0378-3782(88)90053-9. [DOI] [PubMed] [Google Scholar]
  4. Corey L., Whitley R. J., Stone E. F., Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988 Jan 2;1(8575-6):1–4. doi: 10.1016/s0140-6736(88)90997-x. [DOI] [PubMed] [Google Scholar]
  5. Gleeson J. G., Price J. F. Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ. 1988 Jul 16;297(6642):163–166. doi: 10.1136/bmj.297.6642.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Greenough A., Maconochie I., Yuksel B. Recurrent respiratory symptoms in the first year of life following preterm delivery. J Perinat Med. 1990;18(6):489–494. doi: 10.1515/jpme.1990.18.6.489. [DOI] [PubMed] [Google Scholar]
  7. Greenough A., Pool J., Price J. F. Changes in functional residual capacity in response to bronchodilator therapy among young asthmatic children. Pediatr Pulmonol. 1989;7(1):8–11. doi: 10.1002/ppul.1950070104. [DOI] [PubMed] [Google Scholar]
  8. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  9. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  10. Toogood J. H., Jennings B., Baskerville J., Anderson J., Johansson S. A. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis. 1984 Jan;65(1):35–44. [PubMed] [Google Scholar]
  11. Varsano I., Volovitz B., Malik H., Amir Y. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol. 1990 May;85(5):914–920. doi: 10.1016/0091-6749(90)90077-h. [DOI] [PubMed] [Google Scholar]
  12. Vathenen A. S., Knox A. J., Wisniewski A., Tattersfield A. E. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax. 1991 Nov;46(11):811–816. doi: 10.1136/thx.46.11.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yuksel B., Greenough A. Effect of nebulized salbutamol in preterm infants during the first year of life. Eur Respir J. 1991 Oct;4(9):1088–1092. [PubMed] [Google Scholar]
  14. Yuksel B., Greenough A., Green S. Paradoxical response to nebulized ipratropium bromide in pre-term infants asymptomatic at follow-up. Respir Med. 1991 May;85(3):189–194. doi: 10.1016/s0954-6111(06)80078-8. [DOI] [PubMed] [Google Scholar]
  15. Yuksel B., Greenough A. Inhaled sodium cromoglycate for pre-term children with respiratory symptoms at follow-up. Respir Med. 1992 Mar;86(2):131–134. doi: 10.1016/s0954-6111(06)80229-5. [DOI] [PubMed] [Google Scholar]
  16. Yuksel B., Greenough A. Ipratropium bromide for symptomatic preterm infants. Eur J Pediatr. 1991 Oct;150(12):854–857. doi: 10.1007/BF01955008. [DOI] [PubMed] [Google Scholar]
  17. Yuksel B., Greenough A., Maconochie I. Effective bronchodilator treatment by a simple spacer device for wheezy premature infants. Arch Dis Child. 1990 Jul;65(7):782–785. doi: 10.1136/adc.65.7.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yuksel B., Greenough A. Relationship of symptoms to lung function abnormalities in preterm infants at follow-up. Pediatr Pulmonol. 1991;11(3):202–206. doi: 10.1002/ppul.1950110304. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES